Federal Register Notice: FDA is establishing a public docket to receive comments from interested parties on enhancing the utility and usability of the Inactive Ingredient Database (also known as the Inactive Ingredient Guide), which provides information on inactive ingredients in FDA-approved drug products. These comments will help the agency in designing the database and maintaining the information contained therein. To view this notice, click here.
